See more : Goody Science and Technology Co., Ltd. (002694.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Papoutsanis S.A. (PAP.AT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Papoutsanis S.A., a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- NGK Insulators, Ltd. (5333.T) Income Statement Analysis – Financial Results
- Solasia Pharma K.K. (4597.T) Income Statement Analysis – Financial Results
- Aptevo Therapeutics Inc. (APVO) Income Statement Analysis – Financial Results
- Vincerx Pharma, Inc. (VINCU) Income Statement Analysis – Financial Results
- PBT Group Limited (PBG.JO) Income Statement Analysis – Financial Results
Papoutsanis S.A. (PAP.AT)
Industry: Household & Personal Products
Sector: Consumer Defensive
Website: https://www.papoutsanis.gr
About Papoutsanis S.A.
Papoutsanis S.A. produces and sells soaps and liquid cosmetics in Greece. It offers shower gels, shampoos, hand washes, face cleansers, hand and body lotions, body oils, hair conditioners, hair masks and oils, hand creams, soaps, foam baths and shaving foams, liquid soaps, antiseptic hand gels, disinfectants, soap noodles, syndets, and melt and pour products, as well as accessories, such as dental and shaving kits, shower caps, sewing kits, vanity sets, combs, amenities trays, glass caps, shoe-shine sponges, shoe horn and mitt products, bath sponges, slippers, and display stands. The company offers its products under the AHAVA, Aromatics, Eau De Grece, Glycerine Soap, Good to declare, Karavaki, Natura, Olive Care, Olive Soap, Olivia, Olivia Fusion, Olivia Thinks, Papoutsanis, Papoutsanis For Kids, Sarbacane, and Skin Essentials brands. It also exports its products to Europe, the United States, Asia, Oceania, and internationally. The company was formerly known as Plias SA. Papoutsanis S.A. was founded in 1870 and is based in Chalcis, Greece.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 62.27M | 70.75M | 54.77M | 40.84M | 30.67M | 24.24M | 20.78M | 18.03M | 15.61M | 17.17M | 16.03M |
Cost of Revenue | 41.04M | 53.45M | 37.00M | 27.78M | 21.86M | 17.53M | 14.81M | 12.91M | 11.23M | 13.14M | 12.45M |
Gross Profit | 21.24M | 17.30M | 17.77M | 13.07M | 8.81M | 6.71M | 5.96M | 5.12M | 4.39M | 4.03M | 3.58M |
Gross Profit Ratio | 34.11% | 24.45% | 32.45% | 31.99% | 28.73% | 27.67% | 28.70% | 28.40% | 28.11% | 23.46% | 22.31% |
Research & Development | 904.54K | 928.36K | 891.00K | 677.41K | 517.26K | 139.81K | 144.97K | 140.42K | 103.80K | 113.18K | 89.02K |
General & Administrative | 3.59M | 3.38M | 3.22M | 2.40M | 2.62M | 2.12M | 2.11M | 1.94M | 1.69M | 1.63M | 1.56M |
Selling & Marketing | 10.10M | 0.00 | 7.32M | 3.81M | 3.26M | 2.86M | 2.41M | 2.24M | 2.08M | 1.74M | 1.78M |
SG&A | 13.69M | 3.38M | 3.22M | 2.40M | 6.00M | 4.96M | 4.56M | 4.33M | 3.78M | 3.37M | 3.33M |
Other Expenses | 0.00 | -8.93M | -7.32M | -3.81M | -228.92K | -164.67K | -264.66K | -84.15K | -3.11K | 0.00 | 0.00 |
Operating Expenses | 14.59M | 2.70M | 3.42M | 3.06M | 6.75M | 5.27M | 4.97M | 4.55M | 3.88M | 3.28M | 2.90M |
Cost & Expenses | 55.63M | 56.15M | 40.42M | 30.84M | 28.61M | 22.80M | 19.78M | 17.46M | 15.11M | 16.42M | 15.35M |
Interest Income | -573.72K | -275.82K | 7.00 | 64.00 | 332.00 | 491.63K | 421.29K | 542.80K | 556.36K | 611.66K | 595.45K |
Interest Expense | 1.24M | 647.56K | 394.22K | 388.21K | 472.93K | 491.81K | 574.92K | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 2.37M | 2.00M | 1.75M | 1.92M | 1.39M | 1.18M | 1.06M | 1.17M | 936.62K | 1.34M | 1.31M |
EBITDA | 8.64M | 6.66M | 8.30M | 7.68M | 3.72M | 2.78M | 2.17M | 1.83M | 1.56M | 1.84M | 1.40M |
EBITDA Ratio | 13.88% | 10.53% | 15.73% | 19.41% | 11.26% | 10.79% | 9.87% | 9.64% | 9.23% | 10.69% | 8.75% |
Operating Income | 6.65M | 5.45M | 6.87M | 6.01M | 2.06M | 1.44M | 992.21K | 568.82K | 504.84K | 493.62K | 95.25K |
Operating Income Ratio | 10.67% | 7.71% | 12.54% | 14.72% | 6.72% | 5.94% | 4.78% | 3.15% | 3.23% | 2.87% | 0.59% |
Total Other Income/Expenses | -1.61M | -133.09K | -237.66K | -830.33K | -204.78K | -377.20K | -453.64K | -538.25K | -450.25K | -412.37K | -71.50K |
Income Before Tax | 5.04M | 3.93M | 6.10M | 5.33M | 1.86M | 1.06M | 538.57K | 119.73K | 54.59K | 134.48K | 84.36K |
Income Before Tax Ratio | 8.09% | 5.56% | 11.14% | 13.05% | 6.05% | 4.38% | 2.59% | 0.66% | 0.35% | 0.78% | 0.53% |
Income Tax Expense | 954.03K | 937.26K | 1.18M | 1.43M | 507.99K | -43.02K | 118.18K | 170.08K | 469.56K | 202.94K | 195.36K |
Net Income | 4.08M | 3.00M | 4.93M | 3.91M | 1.38M | 1.11M | 420.39K | -50.36K | -414.97K | -68.46K | -111.00K |
Net Income Ratio | 6.55% | 4.23% | 8.99% | 9.56% | 4.50% | 4.56% | 2.02% | -0.28% | -2.66% | -0.40% | -0.69% |
EPS | 0.15 | 0.11 | 0.18 | 0.15 | 0.05 | 0.03 | 0.02 | 0.00 | -0.02 | 0.00 | 0.00 |
EPS Diluted | 0.15 | 0.11 | 0.18 | 0.15 | 0.05 | 0.03 | 0.02 | 0.00 | -0.02 | 0.00 | 0.00 |
Weighted Avg Shares Out | 26.92M | 27.05M | 27.03M | 26.91M | 26.91M | 38.37M | 26.91M | 27.21M | 27.21M | 27.21M | 27.21M |
Weighted Avg Shares Out (Dil) | 26.92M | 27.05M | 27.03M | 26.91M | 26.91M | 38.37M | 26.91M | 27.21M | 27.21M | 27.21M | 27.21M |
Source: https://incomestatements.info
Category: Stock Reports